Oracle Net Income From Continuing Ops from 2010 to 2026
| OHAQ Stock | USD 0.0001 0.00 0.00% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 8.5 M | Current Value 5.3 M | Quarterly Volatility 1.9 M |
Check Oracle Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oracle Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 27.47, Dividend Yield of 0.0 or PTB Ratio of 1.72. Oracle financial statements analysis is a perfect complement when working with Oracle Healthcare Valuation or Volatility modules.
Oracle | Net Income From Continuing Ops | Build AI portfolio with Oracle Stock |
Evaluating Oracle Healthcare's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Oracle Healthcare Acquisition's fundamental strength.
Latest Oracle Healthcare's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Oracle Healthcare Acquisition over the last few years. It is Oracle Healthcare's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oracle Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Oracle Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 6,910,365 | |
| Geometric Mean | 4,362,841 | |
| Coefficient Of Variation | 27.20 | |
| Mean Deviation | 1,007,853 | |
| Median | 7,407,408 | |
| Standard Deviation | 1,879,659 | |
| Sample Variance | 3.5T | |
| Range | 8.5M | |
| R-Value | 0.33 | |
| Mean Square Error | 3.4T | |
| R-Squared | 0.11 | |
| Significance | 0.20 | |
| Slope | 122,038 | |
| Total Sum of Squares | 56.5T |
Oracle Net Income From Continuing Ops History
About Oracle Healthcare Financial Statements
Oracle Healthcare shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Oracle Healthcare investors may analyze each financial statement separately, they are all interrelated. The changes in Oracle Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses on on Oracle Healthcare's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 8.5 M | 5.3 M |
Pair Trading with Oracle Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oracle Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oracle Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving against Oracle Stock
The ability to find closely correlated positions to Oracle Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oracle Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oracle Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oracle Healthcare Acquisition to buy it.
The correlation of Oracle Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oracle Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oracle Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oracle Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Oracle Stock Analysis
When running Oracle Healthcare's price analysis, check to measure Oracle Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oracle Healthcare is operating at the current time. Most of Oracle Healthcare's value examination focuses on studying past and present price action to predict the probability of Oracle Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oracle Healthcare's price. Additionally, you may evaluate how the addition of Oracle Healthcare to your portfolios can decrease your overall portfolio volatility.